Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.
2.
4.

Vbeta18.1(+) and V(alpha)2.3(+) T-cell subsets are associated with house dust mite allergy in human subjects.

Kircher MF, Haeusler T, Nickel R, Lamb JR, Renz H, Beyer K.

J Allergy Clin Immunol. 2002 Mar;109(3):517-23.

PMID:
11898001
5.

Inhibition of human T-cell responses to house dust mite allergens by a T-cell receptor peptide.

Jarman ER, Hawrylowicz CM, Panagiotopolou E, O'Hehir RE, Lamb JR.

J Allergy Clin Immunol. 1994 Nov;94(5):844-52.

PMID:
7963153
7.
8.

IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy.

Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, Akdis CA.

Eur J Immunol. 2003 May;33(5):1205-14.

9.

Effect of specific immunotherapy with house dust mite extract on the bronchial responsiveness of paediatric asthma patients.

Gruber W, Eber E, Mileder P, Modl M, Weinhandl E, Zach MS.

Clin Exp Allergy. 1999 Feb;29(2):176-81.

PMID:
10051720
11.

Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study.

Werfel T, Breuer K, Ruéff F, Przybilla B, Worm M, Grewe M, Ruzicka T, Brehler R, Wolf H, Schnitker J, Kapp A.

Allergy. 2006 Feb;61(2):202-5.

PMID:
16409197
12.

House dust mite allergy: from T-cell epitopes to immunotherapy.

O'Hehir RE, Hoyne GF, Thomas WR, Lamb JR.

Eur J Clin Invest. 1993 Dec;23(12):763-72. Review.

PMID:
7511533
13.

Non-anaphylactic combination of partially deleted fragments of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy.

Takai T, Mori A, Yuuki T, Okudaira H, Okumura Y.

Mol Immunol. 1999 Oct-Nov;36(15-16):1055-65.

PMID:
10698308
14.
15.

[Urticaria in relation to mite sensitivity and immunotherapy with Injection dermatophagoidei farinae].

Xing DR, Wen TH, Yu YL, Wei ZP, Li YM, Han T.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2008 Dec 30;26(6):422-7. Chinese.

PMID:
19288915
16.

Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy.

Schubert R, Eickmeier O, Garn H, Baer PC, Mueller T, Schulze J, Rose MA, Rosewich M, Renz H, Zielen S.

Int Arch Allergy Immunol. 2009;148(3):251-60. doi: 10.1159/000161585. Epub 2008 Oct 10.

PMID:
18849616
17.

[Observation on the effect of the dust mite sublingual immunotherapy for allergic rhinitis].

Du X, Shu C, Xu G, Ma M, Song H.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012 Apr;26(8):372-3. Chinese.

PMID:
22730824
18.

Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.

Ferreira MB, Santos AS, Santos MC, Carlos ML, Barbosa MA, Carlos AG.

Eur Ann Allergy Clin Immunol. 2005 Mar;37(3):96-102.

PMID:
15918296
19.
20.

Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-gamma production in CD4+ T cells.

Lack G, Nelson HS, Amran D, Oshiba A, Jung T, Bradley KL, Giclas PC, Gelfand EW.

J Allergy Clin Immunol. 1997 Apr;99(4):530-8.

PMID:
9111499

Supplemental Content

Support Center